SCHEMBL30764702

SCHEMBL30764702

COc1cc(CN2CC3(C2)CN(C(=O)Cc2ccc(Cl)cc2)C3)ccn1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 6/20 0.46
CHRM2 P08172 1/20 0.46
HSD11B1 P28845 1/20 0.44
FAAH O00519 3/20 0.42
GRM2 Q14416 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
WNK1 Q9H4A3 1/20 0.40
PDCD1LG2 Q9BQ51 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
MGLL Q99685 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30764757 0.84 HSD11B1 (0.46) GHSRCHRM2HSD11B1FAAHMEN1
SCHEMBL30764755 0.78 GAA (0.54) HSD11B1MEN1KMT2AALDH1A1
SCHEMBL30764735 0.78 HSD11B1 (0.51) HSD11B1FAAHMEN1KMT2AALDH1A1
SCHEMBL30764707 0.78 HSD11B1 (0.55) HSD11B1MEN1KMT2AALDH1A1CYP2C9
SCHEMBL30764715 0.76 HSD11B1 (0.51) GHSRCHRM2HSD11B1FAAHMEN1
SCHEMBL30764758 0.75 KDM4E (0.59) GHSRCHRM2HSD11B1MEN1KMT2A
SCHEMBL30764763 0.74 HSD11B1 (0.46) GHSRCHRM2HSD11B1FAAHKMT2A
SCHEMBL30764737 0.74 HSD11B1 (0.46) GHSRCHRM2HSD11B1PDCD1LG2CD274
SCHEMBL30764719 0.73 SMN1; SMN2 (0.53) GHSRCHRM2HSD11B1ALDH1A1
SCHEMBL30764713 0.72 HSD11B1 (0.47) GHSRCHRM2HSD11B1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568968-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Remynd N.V. (BE) 2025-06-18 EP disclosed
WO-2024033479-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS REMYND N.V. (BE) 2024-02-15 WO disclosed